{"id":"W2560424376","doi":"10.1111/dom.12815","title":"Predictors of outcomes in patients with type 2 diabetes in the lixisenatide <scp>GetGoal</scp> clinical trials","year":2016,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"ca_institutions":"LMC Diabetes & Endocrinology (Canada)","funders":"Boehringer Ingelheim; Novo Nordisk; Merck; Sanofi; Roche; GlaxoSmithKline; Janssen Pharmaceuticals; AstraZeneca","keywords":"Medicine; Lixisenatide; Type 2 diabetes; Internal medicine; Placebo; Basal insulin; Basal (medicine); Clinical endpoint; Diabetes mellitus; Insulin; Randomized controlled trial; Glycated hemoglobin; Endocrinology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.02720056,0.0007128667,0.003125765,0.0008822477,0.0003910401,0.001845812,0.0005242394,0.001038955,0.0008065177],"category_scores_gemma":[0.02840342,0.0003849194,0.004531743,0.002515386,0.0004545893,0.0008648076,0.0008260293,0.001378378,0.00009845834],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003652937,"about_ca_system_score_gemma":0.000832943,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005584249,"about_ca_topic_score_gemma":0.001096751,"domain_scores_codex":[0.9754142,0.01758054,0.003470524,0.001321129,0.001769058,0.0004444601],"domain_scores_gemma":[0.9671661,0.01744668,0.01206749,0.001271362,0.001275296,0.0007730612],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.09161284,0.0003718822,0.7768989,0.007038365,0.08316696,0.0002373914,0.0002172368,0.001289369,0.0008071152,0.0002159086,0.001793219,0.03635092],"study_design_scores_gemma":[0.01929751,0.01103126,0.8857493,0.001802299,0.07251097,0.000674202,0.0003195265,0.002862922,0.001054494,0.001015226,0.003586179,0.0000962132],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8562559,0.1348868,0.00235119,0.00122854,0.0003044855,0.0006333816,0.002282758,0.00003914284,0.002017757],"genre_scores_gemma":[0.9894648,0.006593852,0.0009484182,0.0004227152,0.0002504954,0.0005338525,0.00163452,0.00001156828,0.0001398177],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02720056,"threshold_uncertainty_score":0.143852,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02459821376528614,"score_gpt":0.2894897659217755,"score_spread":0.2648915521564894,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}